ASP1517 Phase 3 Clinical Trial -A Multi-center, Randomized, 2-arm, Open-label Study of Intermittent Oral Dosing of ASP1517 for the Treatment of Anemia in ESA-untreated Chronic Kidney Disease Patients Not on Dialysis-

Trial Profile

ASP1517 Phase 3 Clinical Trial -A Multi-center, Randomized, 2-arm, Open-label Study of Intermittent Oral Dosing of ASP1517 for the Treatment of Anemia in ESA-untreated Chronic Kidney Disease Patients Not on Dialysis-

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Roxadustat (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 01 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 21 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top